GastroenterologyNews.net

Gastroenterology Xagena

Xagena Mappa
Medical Meeting
XagenaNewsletter
Xagena Salute

Search results for "Ramucirumab"

There are no agents specifically approved in the United States or European Union for advanced gastric cancer patients. Gastric cancer is the fourth most common cancer in the world and the second-leadi ...


Eli Lilly has announced that the FDA ( Food and Drug Administration ) has approved Cyramza ( Ramucirumab ) as a single-agent treatment for patients with advanced or metastatic gastric cancer or gastro ...


The FDA ( Food and Drug Administration ) has approved Ramucirumab ( Cyramza ) in combination with Paclitaxel as a treatment for people with advanced or metastatic gastric or gastroesophageal junction ...